Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 29074
IPSCIO Record ID: 28042
IPSCIO Record ID: 27156
Gene Therapy field means the administration to humans of Licensed Gene Product for Gene Therapy for the treatment or prevention of any human disease or condition, provided however, that Gene Therapy Field shall not include any treatment or prevention of any type of cardiac or cardiovascular disease or condition. Immunology-based products.
IPSCIO Record ID: 299285
IPSCIO Record ID: 3187
Subsequently, Licensee entered into an Agreement whereby the University of Texas assigned to the Licensee certain patents previously exclusively Licensed to the Licensee.
Chrysalin has been patented in the United States and in some other countries for a number of methods of use, including cardiovascular indications.
A composition of matter patent covering European countries expired in 2007 and the corresponding United States patent expired in 2011. Our other patents for Chrysalin expire between 2021 and 2024.
On January 20, 2012, the Licensee announced the intent to cease all activities related to the development of Chrysalin and to return the patent and other intellectual property we own related to Chrysalin to the original licensor.